Valdes, Talita Alvarenga 
; Botelho, Sabrina Mendes ; Lima, Keli ; Montanari, Carlos Alberto ; Machado Neto, João Agostinho ; Leitão, Andrei
Source: Drugs and Drug Candidates. Unidades: IQSC, ICB, Interunidades em Bioengenharia, FM
Subjects: NEOPLASIAS PROSTÁTICAS, MOLÉCULA, MITOCÔNDRIAS, FÁRMACOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
VALDES, Talita Alvarenga et al. The analysis of the PI3K-AKT-mTOR pathway and mitochondria modulation by a 2-Aminopyridine compound using the metastatic prostate cancer cell line PC-3. Drugs and Drug Candidates, v. 5, n. 1, p. 18 (1-14), 2026Tradução . . Disponível em: https://doi.org/10.3390/ddc5010018. Acesso em: 21 abr. 2026.APA
Valdes, T. A., Botelho, S. M., Lima, K., Montanari, C. A., Machado Neto, J. A., & Leitão, A. (2026). The analysis of the PI3K-AKT-mTOR pathway and mitochondria modulation by a 2-Aminopyridine compound using the metastatic prostate cancer cell line PC-3. Drugs and Drug Candidates, 5( 1), 18 (1-14). doi:10.3390/ddc5010018NLM
Valdes TA, Botelho SM, Lima K, Montanari CA, Machado Neto JA, Leitão A. The analysis of the PI3K-AKT-mTOR pathway and mitochondria modulation by a 2-Aminopyridine compound using the metastatic prostate cancer cell line PC-3 [Internet]. Drugs and Drug Candidates. 2026 ; 5( 1): 18 (1-14).[citado 2026 abr. 21 ] Available from: https://doi.org/10.3390/ddc5010018Vancouver
Valdes TA, Botelho SM, Lima K, Montanari CA, Machado Neto JA, Leitão A. The analysis of the PI3K-AKT-mTOR pathway and mitochondria modulation by a 2-Aminopyridine compound using the metastatic prostate cancer cell line PC-3 [Internet]. Drugs and Drug Candidates. 2026 ; 5( 1): 18 (1-14).[citado 2026 abr. 21 ] Available from: https://doi.org/10.3390/ddc5010018
